ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 261726 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 261726; 2) Community: the network communities that were significantly associated with the response to NSC 261726; 3) Molecule: the relationships between components within communities and NSC 261726; 4) MDR: the compounds that were significantly associated with the NSC 261726.

NSC Compound Enrichment Correlation
NSC 641319 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride 0.0105972823829604 0.21627572
NSC 658088 Null 0.0105972823829604 0.30799252
NSC 666850 Null 0.0105972823829604 0.20885439
NSC 670284 Null 0.0105972823829604 0.22476326
NSC 671189 Null 0.0105972823829604 0.34774109
NSC 684046 Propanedithioamide, 2-[(4-aminocarbonyl-1H-imidazol-5-yl)hydrazono]-N-methyl- 0.0105972823829604 0.37046969
NSC 684496 Benzoic acid, 4-[2-(3,6-dioxo-1,4-cyclohexadienyl)ethyl]-, isopropyl ester 0.0105972823829604 0.32588744
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0105972823829604 0.43166874
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.0105972823829604 0.17920446
NSC 740 Methotrexate 0.0105972823829604 0.30642947
Total:73  Current:19    [First] [Prev] [Next] [Last]